Market news

GARDEN CITY, N.Y., Sept. 02, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that its management team will participate in the 2026 Cantor Global Healthcare Conference, which is being held at the Waldorf Astoria New York, New York on September 9-11, 2026. Fireside Chat Details:Date: Thursday, September 10thTime: 3:55 PM EDT Webc

Beyond Air to receive shares representing 19.99% of Univo's issued and outstanding share capital upon closing Beyond Air eligible to receive up to $32.5 million in development and commercial milestone payments GARDEN CITY, N.Y., Aug. 25, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) today announced that they have entered into a definitive agreement under which UNIVO Pharmaceutical Industries Ltd (“UNIVO”) Univo Pharmaceutical Industries Ltd. ("UNIVO"), a public company whose shares ar

Detailed price information for Beyond Air Inc (XAIR-Q) from The Globe and Mail including charting and trades.

Beyond Air Inc (XAIR) reports flat Q1 revenue but secures $30 million financing, expands global reach, and reaffirms ambitious 2027 growth targets amid FDA review progress.

Moby summary of Beyond Air, Inc.'s Q1 2027 earnings call

Motley Fool Press Release.

Reports $1.8 million revenue for quarter ended June 30, 2026; reaffirms revenue guidance of $8 million for CY2026 and $16-$18 million for CY2027 PMA supplement for second-generation LungFit PH system under FDA review; approval expected in 2H CY2026 Recent financing up to $30.1 million to support ongoing international expansion and U.S. commercial launch of second-generation LungFit PH system, pending regulatory approval Conference call today at 8:00 a.m. ET GARDEN CITY, N.Y., Aug. 13, 2026 (GLOB

The startup goes from a largely pre-revenue air taxi developer into a broader aerospace and defense company.

Detailed price information for Beyond Air Inc (XAIR-Q) from The Globe and Mail including charting and trades.

Detailed price information for Makemytrip Ltd (MMYT-Q) from The Globe and Mail including charting and trades.

GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the s

It’s a fully autonomous attack rotorcraft.

Detailed price information for Beyond Air Inc (XAIR-Q) from The Globe and Mail including charting and trades.

Tipranks Press Release.